Related Experiment Videos
Vascular attack as a therapeutic strategy for cancer
1CRC Gray Laboratory, Mount Vernon Hospital, Northwood, Middlesex, UK.
Cancer Metastasis Reviews
|November 1, 1990
Summary
Tumor blood vessels are abnormal and leaky, impacting nutrient delivery. Existing cancer therapies may exploit these vascular defects to kill tumor cells, highlighting the importance of understanding vascular-mediated mechanisms.
Area of Science:
- Oncology
- Vascular Biology
- Cancer Therapeutics
Background:
- Solid tumors develop abnormal vasculature, characterized by tortuous, thin-walled, and chaotically arranged vessels.
- Tumor blood vessels exhibit increased permeability and suboptimal structure for nutrient delivery.
- These aberrant tumor vessels are crucial for tumor growth and survival.
Purpose of the Study:
- To explore the evidence supporting vascular-mediated mechanisms in existing anti-cancer therapies.
- To highlight the potential for exploiting tumor vascular abnormalities in cancer treatment.
- To emphasize the importance of understanding the vascular effects of anti-cancer agents.
Main Methods:
- Review of existing literature on tumor vasculature and cancer therapy mechanisms.
- Identification of hallmarks of vascular injury relevant to anti-cancer drug action.
- Analysis of how systemic and local vascular changes contribute to therapeutic efficacy.
Main Results:
- Many current cancer therapies likely exert anti-tumor effects through vascular-mediated processes.
- Tumor vascular defects present therapeutic vulnerabilities that can be exploited.
- Understanding these vascular mechanisms is key to optimizing existing treatments.
Conclusions:
- Existing therapies may possess inherent anti-vascular effects contributing to tumor cell death.
- Failure to recognize vascular-mediated actions risks discarding effective anti-cancer agents.
- Further research into tumor vascular biology can enhance cancer treatment strategies.